Surgical ablation procedure can restore sinus rhythm (SR) in patients with atrial fibrillation (AF) undergoing cardiac surgery. However, it is not known whether it has any impact on clinical outcomes. There is a need for a randomized trial with long-term follow-up to study the outcome of surgical ablation in patients with coronary and/or valve disease and AF. Patients are prospectively enrolled and randomized either to group A (cardiac surgery with left atrial ablation) or group B (cardiac surgery alone). The primary efficacy outcome is the SR presence (without any AF episode) during a 24-hour electrocardiogram after 1 year. The primary safety outcome is the combined end point of death, myocardial infarction, stroke, and renal failure at 30 days. Long-term outcomes are a composite of total mortality, stroke, bleeding, and heart failure at 1 and 5 years. We finished the enrollment with a total of 224 patients from 3 centers in 2 countries in December 2011. Currently, the incomplete 1-year data are available, and the patients who enrolled first will have their 5-year visits shortly. PRAGUE-12 is the largest study to be conducted so far comparing cardiac surgery with surgical ablation of AF to cardiac surgery without ablation in an unselected population of patients who are operated on for coronary and/or valve disease. Its long-term results will lead to a better recognition of ablation's potential clinical benefits.

Cardiocenter Charles University Prague Czech Republic

Zobrazit více v PubMed

Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369–2429. PubMed

Chugh S, Blackshear J, Shen W, et al. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 2001;37:371–378. PubMed

Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: executive summary. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eur Heart J. 2007;28:2803–2817. PubMed

Stewart S, Hart CL, Hole DJ, et al. A population‐based study of the longterm risks associated with atrial fibrillation: 20‐year follow‐up of the Renfrew/Paisley study. Am J Med. 2002;113:359–364. PubMed

Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J. 2010;31:967–975. PubMed

Thrall G, Lane D, Carroll D, et al. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med. 2006;119:448.e1–e19. PubMed

Wu EQ, Birnbaum HG, Mareva M, et al. Economic burden and co‐morbidities of atrial fibrillation in a privately insured population. Curr Med Res Opin. 2005;21:1693–1699. PubMed

Stewart S, Murphy NF, Walker A, et al. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart. 2004;90:286–292. PubMed PMC

Williams JM, Ungerleider RM, Lofland GK, et al. Left atrial isolation: new technique for the treatment of supraventricular arrhythmias. J Thorac Cardiovasc Surg. 1980;80:373. PubMed

Guiraudon GM, Campbell CS, Jones DL, et al. Combined sinoatrial node atrioventricular node isolation: a surgical alternative to His bundle ablation in patients with atrial fibrillation. Circulation. 1985;72(suppl 3):220.

Cox JL, Schuessler RB, D'Agostino HJ, et al. The surgical treatment of atrial fibrillation. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg. 1991;101:569–583. PubMed

Cox JL. The first Maze procedure. J Thorac Cardiovasc Surg. 2011;141:1093–1097. PubMed

Damiano RJ Jr, Gaynor SL, Bailey M, et al. The long‐term outcome of patients with coronary disease and atrial fibrillation undergoing the Cox maze procedure. J Thorac Cardiovasc Surg. 2003;126:2016–2021. PubMed

Prasad SM, Maniar HS, Camillo CJ, et al. The Cox maze III procedure for atrial fibrillation: long‐term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg. 2003;126:1822–1827. PubMed

Bando K, Kobayashi J, Sasako Y, et al. Effect of maze procedure in patients with atrial fibrillation undergoing valve replacement. J Heart Valve Dis. 2002;11:719–724. PubMed

Ad N, Cox JL. Stroke prevention as an indication for the Maze procedure in the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg. 2000;12:56–62. PubMed

Khargi K, Hutten BA, Lemke B, et al. Surgical treatment of atrial fibrillation; a systematic review. Eur J Cardiothorac Surg. 2005;27:258–265. PubMed

Gammie JS, Haddad M, Milford‐Beland S, et al. Atrial fibrillation correction surgery: lessons from the Society of Thoracic Surgeons National Cardiac Database. Ann Thorac Surg. 2008;85: 909–914. PubMed

Abreu Filho CAC, Lisboa LAF, Dallan LAO, et al. Effectiveness of the Maze procedure using cooled‐tip radiofrequency ablation in patients with permanent atrial fibrillation and rheumatic mitral valve disease. Circulation. 2005;112(suppl 9):I20–I25. PubMed

Deneke T, Khargi K, Grewe PH, et al. Efficacy of an additional MAZE procedure using cooled‐tip radiofrequency ablation in patients with chronic atrial fibrillation and mitral valve disease. A randomized, prospective trial. Eur Heart J. 2002;23:558–566. PubMed

Doukas G, Samani NJ, Alexiou C, et al. Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial. JAMA. 2005;294: 2323–2329. PubMed

Schuetz A, Schulze CJ, Sarvanakis KK, et al. Surgical treatment of permanent atrial fibrillation using microwave energy ablation: a prospective randomized clinical trial. Eur J Cardiothorac Surg. 2003;24:475–480. PubMed

Blomstrom‐Lundqvist C, Johansson B, Berglin E, et al. A randomized double‐blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF). Eur Heart J. 2007;28:2902–2908. PubMed

Chevalier P, Leizorovicz A, Maureira P, et al. Left atrial radiofrequency ablation during mitral valve surgery: A prospective randomized multicentre study (SAFIR). Arch Cardiovasc Dis. 2009;102:769–775. PubMed

de Lima GG, Kalil RAK, Leiria TLL, et al. Randomized study of surgery for patients with permanent atrial fibrillation as a result of mitral valve disease. Ann Thorac Surg. 2004;77:2089. PubMed

Von Oppell U, Masani N, O'Callaghan P, et al. Mitral valve surgery plus concomitant atrial fibrillation ablation is superior to mitral valve surgery alone with an intensive rhythm control strategy. Eur J Cardiothorac Surg. 2009;35:641–650. PubMed

Albrecht A, Kalil RAK, Schuch L, et al. Randomized study of surgical isolation of the pulmonary veins for correction of permanent atrial fibrillation associated with mitral valve disease. J Thorac Cardiovasc Surg. 2009;138:454–459. PubMed

Kong MH, Lopes RD, Piccini JP, et al. Surgical Maze procedure as a treatment for atrial fibrillation: a meta‐analysis of randomized controlled trials. Cardiovasc Ther. 2010;28:311–326. PubMed

McNamara RL, Brass LM, Drozda JP Jr, et al. American College of Cardiology; American Heart Association. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation. Circulation. 2004;109:3223–3324. PubMed

Shemin R, Cox J, Gillinov A, et al. Guidelines for reporting data and outcomes for the surgical treatment of atrial fibrillation. Ann Thorac Surg. 2007;83:1225–1230. PubMed